ArticlePharmaceuticals (Basel, Switzerland)2026
Development of Pseudoginsenoside RT2 as a Novel Gut-Selective Agent: Integrated Pharmacodynamic and Pharmacokinetic Evaluation of an Ocotillol Ginsenoside for Ulcerative Colitis.
Zhuoqiao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.